JP Morgan Chase’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $204M | Sell |
3,411,000
-1,128,700
| -25% | -$65.8M | 0.01% | 692 |
|
|
2025
Q4 | $245M | Buy |
4,539,700
+2,704,500
| +147% | +$130M | 0.02% | 602 |
|
|
2025
Q3 | $82.8M | Buy |
1,835,200
+1,685,200
| +1,123% | +$78.7M | 0.01% | 1098 |
|
|
2025
Q2 | $6.94M | Sell |
150,000
-2,019,400
| -93% | -$99.1M | ﹤0.01% | 2864 |
|
|
2025
Q1 | $132M | Buy |
2,169,400
+1,920,000
| +770% | +$112M | 0.01% | 808 |
|
|
2024
Q4 | $14.1M | Hold |
249,400
| – | – | ﹤0.01% | 2378 |
|
|
2024
Q3 | $12.9M | Hold |
249,400
| – | – | ﹤0.01% | 2390 |
|
|
2024
Q2 | $10.4M | Buy |
249,400
+218,400
| +705% | +$9.77M | ﹤0.01% | 2435 |
|
|
2024
Q1 | $1.68M | Sell |
31,000
-374,800
| -92% | -$19.1M | ﹤0.01% | 3980 |
|
|
2023
Q4 | $20.8M | Sell |
405,800
-365,800
| -47% | -$19.2M | ﹤0.01% | 1821 |
|
|
2023
Q3 | $44.8M | Buy |
771,600
+483,500
| +168% | +$29.6M | ﹤0.01% | 1167 |
|
|
2023
Q2 | $18.4M | Sell |
288,100
-111,200
| -28% | -$7.46M | ﹤0.01% | 1760 |
|
|
2023
Q1 | $27.7M | Sell |
399,300
-452,100
| -53% | -$31.9M | ﹤0.01% | 1428 |
|
|
2022
Q4 | $61.3M | Buy |
851,400
+209,300
| +33% | +$15.8M | 0.01% | 1009 |
|
|
2022
Q3 | $45.6M | Buy |
642,100
+60,800
| +10% | +$4.41M | 0.01% | 1080 |
|
|
2022
Q2 | $44.8M | Sell |
581,300
-828,100
| -59% | -$63.1M | 0.01% | 1099 |
|
|
2022
Q1 | $103M | Buy |
1,409,400
+1,351,200
| +2,322% | +$90.7M | 0.01% | 815 |
|
|
2021
Q4 | $3.63M | Hold |
58,200
| – | – | ﹤0.01% | 3328 |
|
|
2021
Q3 | $3.44M | Sell |
58,200
-46,200
| -44% | -$3.04M | ﹤0.01% | 3338 |
|
|
2021
Q2 | $6.98M | Buy |
104,400
+89,400
| +596% | +$5.83M | ﹤0.01% | 2747 |
|
|
2021
Q1 | $947K | Buy |
15,000
+8,100
| +117% | +$504K | ﹤0.01% | 4274 |
|
|
2020
Q4 | $428K | Sell |
6,900
-65,000
| -90% | -$4M | ﹤0.01% | 4462 |
|
|
2020
Q3 | $4.31M | Sell |
71,900
-578,300
| -89% | -$34.8M | ﹤0.01% | 2695 |
|
|
2020
Q2 | $38.2M | Sell |
650,200
-23,200
| -3% | -$1.39M | 0.01% | 1016 |
|
|
2020
Q1 | $37.5M | Sell |
673,400
-5,013,800
| -88% | -$306M | 0.01% | 922 |
|
|
2019
Q4 | $365M | Buy |
5,687,200
+4,576,200
| +412% | +$262M | 0.07% | 289 |
|
|
2019
Q3 | $56.3M | Sell |
1,111,000
-9,800
| -0.9% | -$461K | 0.01% | 889 |
|
|
2019
Q2 | $50.5M | Sell |
1,120,800
-838,500
| -43% | -$39.1M | 0.01% | 951 |
|
|
2019
Q1 | $93.5M | Buy |
1,959,300
+1,129,600
| +136% | +$56.3M | 0.02% | 672 |
|
|
2018
Q4 | $43.1M | Buy |
829,700
+58,600
| +8% | +$3.15M | 0.01% | 975 |
|
|
2018
Q3 | $47.9M | Buy |
771,100
+77,100
| +11% | +$4.58M | 0.01% | 1045 |
|
|
2018
Q2 | $38.4M | Buy |
694,000
+387,400
| +126% | +$20.9M | 0.01% | 1124 |
|
|
2018
Q1 | $19.4M | Sell |
306,600
-300,700
| -50% | -$19.3M | ﹤0.01% | 1535 |
|
|
2017
Q4 | $37.2M | Buy |
607,300
+204,900
| +51% | +$12.8M | 0.01% | 1144 |
|
|
2017
Q3 | $25.4M | Sell |
402,400
-109,500
| -21% | -$6.39M | 0.01% | 1337 |
|
|
2017
Q2 | $28.5M | Sell |
511,900
-738,800
| -59% | -$40.2M | 0.01% | 1220 |
|
|
2017
Q1 | $68M | Sell |
1,250,700
-63,900
| -5% | -$3.5M | 0.02% | 789 |
|
|
2016
Q4 | $76.8M | Sell |
1,314,600
-969,742
| -42% | -$53M | 0.02% | 691 |
|
|
2016
Q3 | $123M | Buy |
2,284,342
+2,276,200
| +27,956% | +$146M | 0.03% | 497 |
|
|
2016
Q2 | $599K | Buy |
8,142
+1,942
| +31% | +$137K | ﹤0.01% | 3367 |
|
|
2016
Q1 | $396K | Sell |
6,200
-45,100
| -88% | -$2.84M | ﹤0.01% | 3418 |
|
|
2015
Q4 | $3.53M | Hold |
51,300
| – | – | ﹤0.01% | 2434 |
|
|
2015
Q3 | $3.04M | Hold |
51,300
| – | – | ﹤0.01% | 2536 |
|
|
2015
Q2 | $3.41M | Hold |
51,300
| – | – | ﹤0.01% | 2620 |
|
|
2015
Q1 | $3.31M | Sell |
51,300
-1,033,411
| -95% | -$64.7M | ﹤0.01% | 2604 |
|
|
2014
Q4 | $64M | Buy |
1,084,711
+806,286
| +290% | +$45.5M | 0.01% | 815 |
|
|
2014
Q3 | $14.3M | Buy |
278,425
+28,425
| +11% | +$1.42M | ﹤0.01% | 1671 |
|
|
2014
Q2 | $12.1M | Buy |
+250,000
| New | +$12.3M | ﹤0.01% | 1643 |
|
|
2014
Q1 | – | Sell |
-274,400
| Closed | -$14.6M | – | 3607 |
|
|
2013
Q4 | $14.6M | Buy |
274,400
+37,900
| +16% | +$1.93M | ﹤0.01% | 1542 |
|
|
2013
Q3 | $10.9M | Buy |
236,500
+12,800
| +6% | +$562K | ﹤0.01% | 1709 |
|
|
2013
Q2 | $10M | Buy |
+223,700
| New | +$9.71M | ﹤0.01% | 1684 |
|
Other funds holding BMY
VCM
VPM
JP Morgan Chase's BMY Position: Q1 2026 in Review
JP Morgan Chase increased its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, buying an estimated $997M and bringing the position to 92,475,194 shares worth $5.52B. The position accounts for 0.35% of the portfolio, ranked #51.
JP Morgan Chase first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.53B in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- JP Morgan Chase held 92,475,194 shares of Bristol-Myers Squibb worth $5.52B as of Q1 2026.
- JP Morgan Chase bought 17,107,541 Bristol-Myers Squibb shares in Q1 2026, an estimated $997M.
- Bristol-Myers Squibb made up 0.35% of JP Morgan Chase's portfolio in Q1 2026, its #51 holding.
- JP Morgan Chase first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Bristol-Myers Squibb position peaked at $7.53B in Q2 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.